Key result
Editorial outlines indications, device selection, and AV block risk for transcatheter perimembranous VSD closure.
Why the study?
Percutaneous transcatheter closure of ventricular septal defect is increasingly reported but complications and regulatory approval remain issues, especially for perimembranous VSD.
Percutaneous transcatheter closure of perimembranous VSD is increasingly reported, utilizing devices like the Amplatzer Duct Occluder off-label due to complication risks with dedicated devices.
Answers are grounded in this paper and cite their sources.
A subset of observed PMVSD patients may qualify for off-label ADO closure; leaves open prospective safety trials before wider use.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kenji Hoshino (2019) conducted an editorial in Ventricular Septal Defect. Percutaneous Transcatheter Closure was evaluated. This editorial discusses the indications, device selection, and complications such as complete atrioventricular block associated with percutaneous transcatheter closure of perimembranous ventricular septal defects.
Synapse has enriched 10 related papers. Consider them for comparative context: